FTSE Med 100 Semi-Annual Review

10 November 2004


The FTSE Med Index Committee approved the following changes to the FTSE Med 100 Index. The changes will be effective after the close of business on Friday, 19 November 2004 (i.e. on Monday, 22 November 2004).

PERIODIC REVIEW OF CONSTITUENTS

Additions to the FTSE Med 100 Index:

Stock Name Sedol Country Rank Investability Weight Reason
Alvarion Ltd 6382724 Israel 35 75% Auto Addition
Israel Phoenix Assurance Co 6460590 Israel 58 50% Auto Addition
Gen.Hellen Bnk/R 4363709 Greece 62 75% Auto Addition
Frutarom 6353418 Israel 80 50% Auto Addition

Deletions from the FTSE Med 100 Index:

Stock Name Sedol Country Rank Reason
General Construction (Cr) 4405946 Greece 109 Rebalancing Deletion
Michaniki S.A. (Cr) 4588784 Greece 110 Rebalancing Deletion
Hellenic Sugar Inds 4416614 Greece 113 Rebalancing Deletion
Tiletypos (Cr) 4577630 Greece 117 Rebalancing Deletion

Reserve list for the FTSE Med 100 Index:

With immediate effect, the following reserve list will be used in the event that one or more constituents are deleted during the period up to the next semi-annual review:

Stock Name Sedol Country Rank Investability Weight
FIBI Holdings 6339429 Israel 92 100%
Halkor S.A 5266142 Greece 96 30%
Serantis 7124958 Greece 97 75%
Elbit Medical Imaging 6308902 Israel 99 30%
American Israeli Paper Mills 6026099 Israel 102 75%

Investability Weight Changes for the FTSE Med 100 Index:

There are no investability weight changes for the FTSE Med 100 Index.

For index related enquiries or further information about FTSE please contact:
Client Services in UK:Tel: +44 (0) 20 7448 1810 and
Client Services in US:Tel: Domestic: + 1 888 747 FTSE (3873); International: +1 212 641 6166
Client Services in Asia Pacific:Tel: +852 2230 5800 or +65 6223 3738 or +81 3 3581 2796

Or, email your enquiries to info@ftse.com or visit our website at www.ftse.com


Terms of Use | Copyright © FTSE